Rationale for Combing Stereotactic Body Radiation Therapy with Immune Checkpoint Inhibitors in Medically Inoperable Early-Stage Non-Small Cell Lung Cancer

SIMPLE SUMMARY: The rate of recurrence remains high for lymph node negative early-stage non-small cell lung cancer that are over 2–3 cm in size following stereotactic body radiation therapy (SBRT). This is due to the increased incidence of out-of-field failures, which warrants the addition of system...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Alexander, Nguyen, Nam P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264861/
https://www.ncbi.nlm.nih.gov/pubmed/35804917
http://dx.doi.org/10.3390/cancers14133144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264861/
https://www.ncbi.nlm.nih.gov/pubmed/35804917
http://dx.doi.org/10.3390/cancers14133144

Ejemplares similares